• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Dr. Reddy's Laboratories Ltd.
    07 Apr 2025
    1248.60
    0.04%
    Here's why Dr. Reddy's share slipped 8%, hit 52-week low on Monday, April 7
    Business Standard
    The fall in Dr. Reddy's share price came after the company announced that it received approximately Rs 2,395-crore show cause notice from I-T department
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
    logo
    Dr. Reddy's Laboratories Ltd.
    05 Apr 2025, 10:42PM
    1248.60
    0.04%
    Dr Reddy's gets over Rs 2,395 crore show cause notice from I-T authority
    Business Standard
    Dr Reddy's Laboratories Ltd on Saturday said it has received a showcause notice from the income tax authority with a proposed demand of over Rs 2,395 crore from it related to the merger of Dr Reddy's Holding Ltd (DRHL) with itself. The company has received a show cause notice on April 4, 2025, from the office of the Assistant Commissioner of Income Tax, Hyderabad, Dr Reddy's Laboratories Ltd said in a regulatory filing. It requires the company to respond as to why notice should not be issued for assessment of income alleged to be escaped from tax consequent to the merger of DRHL into Dr Reddy's Laboratories Ltd (DRL) under the scheme of amalgamation approved by the National Company Law Tribunal (NCLT), Hyderabad on April 5, 2022, the filing added. "The notice quantifies the proposed demand of Rs 23,95,81,79,470," the company said. DRL asserted that said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws. "Further this was approved by
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd. is trading below its 30 day SMA of 1278.6
    Dr. Reddy's faces 2,395 crore tax reassessment notice
    Business Line | 05 Apr 2025, 09:46PM
    logo
    Sun Pharmaceutical Industries Ltd.
    04 Apr 2025, 08:31PM
    1654.70
    1.44%
    Higher tariffs may significantly dent profits of pharma companies
    Business Standard
    Companies such as Sun Pharma which have a significant specialty portfolio could be less impacted than Indian peers in the US market given lower competition in niche segments
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 1351 to 1326 in Jun 2025 qtr
    logo
    Strides Pharma Science Ltd.
    04 Apr 2025, 06:45PM
    834.10
    0.21%
    Strides Pharma initiates Class-II recall of Testosterone Gel in US
    Business Standard
    The recall was voluntarily initiated by Strides Pharma on March 5, 2025, and remains ongoing. Consignees have been informed about this recall formerly, although public press release has not been issue
    Copy LinkShare onShare on Share on Share on
    Promoters unpledged 1.88% of shares in last quarter. Total pledge stands at 50.10% of promoter holdings
    Strides Pharma Recalls Over 4.4 Lakh Cartons Of Testosterone Gel In US Market
    NDTV Profit | 04 Apr 2025, 04:48PM
    logo
    Laurus Labs Ltd.
    04 Apr 2025
    863.00
    -0.16%
    Laurus Labs to invest 5,000 crore in new manufacturing plant in Andhra Pradesh
    Business Line
    The State government will allot land for the proposed plant in Rambilli village, Anakapalli district
    Copy LinkShare onShare on Share on Share on
    Laurus Labs Ltd. is trading above its 200 day SMA of 684.7
    logo
    Sai Life Science Ltd.
    03 Apr 2025
    866.25
    -1.85%
    Sai Life Sciences sets up Peptide Research Center in Hyderabad
    Business Line
    The new Peptide Research Center reflects our commitment to meeting the growing demand for complex peptide synthesis and conjugation,' says Krishna Kanumuri, CEO & Managing Director
    Copy LinkShare onShare on Share on Share on
    Sai Life Science Ltd. has gained 20.82% in the last 6 Months
    logo
    Medicamen Biotech Ltd.
    03 Apr 2025
    303.20
    -1.54%
    Here's why Medicamen Biotech shares skyrocketed 12% in trade on April 3
    Business Standard
    Medicamen Biotech stock rose following the announcement of a strategic partnership with XGX Pharma, a European company.
    Copy LinkShare onShare on Share on Share on
    Medicamen Biotech Ltd. has lost -39.41% in the last 6 Months
    W
    Wanbury Ltd.
    03 Apr 2025
    256.25
    0.99%
    India's pharma sector spared from US tariff hikes as Wanbury plans investor visit
    Business Line
    Wanbury Limited is preparing for an investors and analysts plant visit on April 10 following major plant upgrades completed in Q3
    Copy LinkShare onShare on Share on Share on
    Wanbury Ltd. is trading below all available SMAs
    logo
    Torrent Pharmaceuticals Ltd.
    03 Apr 2025
    3526.00
    0.32%
    Pharma stocks that you can keep in your portfolio despite US tariff woes
    Business Standard
    Tausif Shaikh, India analyst for pharma and healthcare, BNP Paribas India, prefers domestic-focused companies like Torrent Pharmaceuticals, and JB Chemicals and Pharmaceuticals in the sector
    Copy LinkShare onShare on Share on Share on
    Torrent Pharmaceuticals Ltd. is trading above its 200 day SMA of 3330.1
    logo
    Lupin Ltd.
    03 Apr 2025
    US FDA Observation
    1937.30
    -1.84%
    Lupin announces acquisition of UK-Based Renascience Pharma for GBP 12.3 mn
    Business Standard
    Renascience, incorporated in 2015, supplies niche branded bio-generic products catering to primary and secondary care in the UK
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd.'s price crossed below 50Day SMA today
    Lupin's UK Subsidiary Acquires Pharma Firm For Rs 135 Crore
    NDTV Profit | 02 Apr 2025
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • DSM Fresh Foods
    • Greenleaf Envirotech
    • NSB BPO Solutions
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd (RA SEBI Reg No: INH000022507)